Menu Close

Articles on FDA

Displaying 1 - 20 of 94 articles

Research suggests that about 20% of all prescriptions are administered “off-label.” Hafakot/iStock via Getty Images Plus

Off-label’ use is common in medicine – a bioethicist and legal philosopher explain why the COVID-19 vaccines are different

The CDC’s COVID-19 vaccine provider agreement prohibits health care professionals from administering the vaccines in people for whom they are not yet authorized or approved. But this departs from longstanding norms.
Ethics are important to vaccination decisions because while science can clarify some of the costs and benefits, it cannot tell us which costs and benefits matter most to us. THE CANADIAN PRESS/Frank Gunn

Ethical decisions: Weighing risks and benefits of approving COVID-19 vaccination in children ages 5-11

When making the decision whether to vaccinate children aged five to 11 against COVID-19, regulators in Canada must rely on sound ethics as well as sound science.
Pregnancy poses significant risks for severe illness or death from COVID-19, for both mother and baby. ArtMarie/E+ via Getty Images

Vaccination against COVID-19 supports a healthy pregnancy by protecting both mother and child – an immunologist explains the maternal immune response

In light of mounting research showing the serious risks of contracting COVID-19 during pregnancy, the CDC is re-upping its urgency that pregnant women get their shots.
Protesters gather at Indiana University in June 2021 to demonstrate against mandatory COVID-19 vaccinations for students, staff and faculty. SOPA Images/LightRocket via Getty Images

Forceful vaccine messages backfire with holdouts – how can it be done better?

Subtly shifting the crafting and delivery of public health messaging on COVID-19 vaccines could go a long way toward persuading many of the unvaccinated to get the shot.
FDA approval of Pfizer’s COVID-19 vaccine may boost vaccination rates among those who have been hesitant to get the shot. (AP Photo/Jessica Hill)

Pfizer’s COVID-19 vaccine now has full FDA approval. Here’s what that means for unvaccinated people, organizations and pharma

The U.S. FDA has approved the first COVID-19 vaccine. How is approval different from emergency use authorization, and what difference will it make to a vaccine that’s already in global use?
Alzheimer’s disease is characterized by progressive memory loss, spatial disorientation and many other cognitive and behavioural disorders that ultimately lead to a state of total dependence. (Shutterstock)

FDA approval of controversial Alzheimer’s drug could delay discovery of more promising treatments

The new drug is based on the idea that a build-up of amyloid in the brain leads to the disease. But that hypothesis has been under scrutiny lately.
Do the benefits of approving a drug before confirming it works outweigh the potential costs? monkeybusinessimages/iStock via Getty Images Plus

The FDA’s big gamble on the new Alzheimer’s drug

The FDA approved Alzheimer’s disease drug aducanumab despite minimal evidence of its efficacy. Whether this decision ultimately hurts or helps patients depends on data researchers don’t yet have.
Exterior of the Pfizer World headquarters building. Pfizer produced the first COVID-19 vaccine to gain emergency use authorization. Sam Aronov/Pacific Press/LightRocket via Getty Images

Why is the FDA funded in part by the companies it regulates?

The FDA receives almost half its funding from companies it regulates, such as drug and medical device makers. Is this something you should be concerned about?

Top contributors

More